CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Biogen Inc 's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


Return On Assets (Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Total Assets Change -9.6 % -9.28 % -2.95 % -1.23 % 7.69 %
Y / Y Net Income Change -75.17 % -54.47 % 7.52 % -1.15 % 52.37 %
Net Income (TTM) in Millions 4,061 5,143 5,985 5,872 5,889
Return On Assets (TTM) 16.05 % 19.82 % 22.51 % 21.93 % 21.92 %
Total Ranking # 237 # 183 # 134 # 156 # 184
Total Assets (TTM) in Millions 24,619 24,934 25,512 26,119 27,234
Seq. Total Assets Change -1.26 % -2.26 % -2.33 % -4.09 % -0.91 %
Seq. Net Income Change -49.21 % -56.18 % 15.36 % -3.27 % -6.87 %


Roa Comment
Biogen Inc yielded Return on Asset in IV. Quarter above company average, at 16.05 %.

Return on assets decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 56 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from 183 to 237.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 14
Sector # 57
Overall # 237

Return On Assets Statistics
High Average Low
23.39 %
13.42 %
0.42 %
(March 31, 2015)   (June 30. 2006)


Financial Statements
Biogen Inc 's Assets $ 24,619 Millions BIIB's Balance sheet
Biogen Inc 's Income $ 358 Millions Quarterly BIIB's Income Statement
BIIB's Income by Division See BIIB's Income by Division



Annual Return On Assets (Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
(Dec 31 2016)
FY 2016
Y / Y Total Assets Change -9.6 % 7.69 % 6.92 % 3.39 % 17.29 %
Total Assets in Millions 24,619 27,234 25,289 23,653 22,877
Y / Y Net Income Change -31.04 % 31.62 % 67.56 % -27.75 % 2.85 %
Net Income in Millions 4,061 5,889 4,474 2,670 3,696
Return On Assets 16.49 % 21.62 % 17.69 % 11.29 % 16.15 %




Roa Comment
In the fiscal year 2020 Biogen Inc 's ROA decreased compare to previous year to 16.49 %, due to detoriation of net income -31.04 % to $4,060.50 millions, from $5,888.50 millions a year ago, as BIIB's assets were $24,618.90 millions.


More Return On Equity Ratios
Biotechnology & Drugs Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BIIB's Roa Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for BIIB's Competitors
Roa for Biogen Inc 's Suppliers
Return On Asstes for BIIB's Customers

You may also want to know
BIIB's Roi BIIB's Inventory Turnover Ratio BIIB's Growth Rates BIIB's Dividend Comparisons
BIIB's Annual Roi BIIB's Profitability Ratios BIIB's Asset Turnover Ratio BIIB's Dividend Growth
BIIB's Roe BIIB's Valuation Ratios BIIB's Financial Strength Ratios BIIB's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2020, within Healthcare Sector ROA
Siga Technologies Inc  42.50 %
Redhill Biopharma Ltd   42.26 %
Retractable Technologies Inc  42.25 %
Zomedica Corp   42.14 %
Align Technology inc   41.21 %
Surface Oncology Inc   36.65 %
Oramed Pharmaceuticals Inc   35.98 %
Bio rad Laboratories Inc   34.78 %
Antares Pharma Inc   34.69 %
Purple Biotech Ltd   33.50 %
The Cooper Companies Inc   33.28 %
Bionexus Gene Lab Corp  32.87 %
Innoviva inc   32.74 %
National Research Corporation  30.21 %
Viemed Healthcare Inc   29.64 %
Idexx Laboratories Inc  28.44 %
Vertex Pharmaceuticals Inc  25.73 %
Blueprint Medicines Corporation  25.07 %
Halozyme Therapeutics Inc   24.32 %
Elite Pharmaceuticals Inc  23.87 %
Chemed Corporation  23.79 %
Ironwood Pharmaceuticals inc   22.36 %
Regeneron Pharmaceuticals Inc   22.15 %
Integrated Biopharma Inc  21.83 %
Seagen Inc   21.80 %
Mettler toledo International Inc   21.63 %
Corcept Therapeutics Inc  20.69 %
Infusystem Holdings Inc  20.16 %
Hologic Inc  19.44 %
Petmed Express Inc  19.11 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TNTY's Profile

Stock Price

TNTY's Financials

Business Description

Fundamentals

Charts & Quotes

TNTY's News

Suppliers

TNTY's Competitors

Customers & Markets

Economic Indicators

TNTY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071